
Arunjyoti Bio (ABVL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
52.8M
Gross Profit
51.5M
97.60%
Operating Income
-4.6M
-8.71%
Net Income
-19.9M
-37.67%
Balance Sheet Metrics
Total Assets
596.2M
Total Liabilities
272.4M
Shareholders Equity
323.8M
Debt to Equity
0.84
Cash Flow Metrics
Revenue & Profitability Trend
Arunjyoti Bio Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 278.8M | 204.3M | 17.4M | 29.7M | 55.1M |
Cost of Goods Sold | 52.2M | 85.2M | 15.0M | 28.8M | 48.1M |
Gross Profit | 226.6M | 119.1M | 2.4M | 895.4K | 7.0M |
Gross Margin % | 81.3% | 58.3% | 13.8% | 3.0% | 12.7% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 7.0M | 206.0K | 1.5M | 2.6M |
Other Operating Expenses | 86.4M | 37.8M | 451.0K | 819.0K | 1.1M |
Total Operating Expenses | 86.4M | 44.8M | 657.0K | 2.3M | 3.6M |
Operating Income | 19.7M | 7.7M | 1.7M | -2.0M | 963.1K |
Operating Margin % | 7.1% | 3.8% | 9.5% | -6.8% | 1.7% |
Non-Operating Items | |||||
Interest Income | - | 369.0K | 0 | 0 | 0 |
Interest Expense | 25.9M | 21.1M | 74.0K | 10.7K | 58.9K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | -3.4M | -13.0M | 1.6M | 760.2K | 922.5K |
Income Tax | 14.8M | -9.5M | 410.0K | 197.7K | 239.8K |
Effective Tax Rate % | 0.0% | 0.0% | 26.0% | 26.0% | 26.0% |
Net Income | -18.2M | -3.5M | 1.2M | 562.6K | 682.6K |
Net Margin % | -6.5% | -1.7% | 6.7% | 1.9% | 1.2% |
Key Metrics | |||||
EBITDA | 52.9M | 28.2M | 1.7M | 770.9K | 981.3K |
EPS (Basic) | - | ₹-0.03 | ₹0.01 | ₹0.00 | ₹0.01 |
EPS (Diluted) | - | ₹-0.03 | ₹0.01 | ₹0.00 | ₹0.01 |
Basic Shares Outstanding | - | 112990049 | 112990049 | 112984593 | 112984593 |
Diluted Shares Outstanding | - | 112990049 | 112990049 | 112984593 | 112984593 |
Income Statement Trend
Arunjyoti Bio Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 5.9M | 859.0K | 252.0K | 73.6K | 8.1M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 39.6M | 27.3M | 7.8M | 5.4M | 18.4M |
Inventory | 26.2M | 29.3M | 8.8M | 0 | 259.5K |
Other Current Assets | 71.4M | 2.6M | 711.0K | 644.8K | 644.8K |
Total Current Assets | 148.0M | 112.8M | 55.3M | 10.9M | 32.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 433.3M | 45.3M | 0 | 0 | - |
Goodwill | - | 0 | 0 | 0 | 0 |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 15.0M | 12.3M | 0 | 0 | - |
Total Non-Current Assets | 448.3M | 427.1M | 303.7M | 10.0M | 15.0M |
Total Assets | 596.2M | 539.9M | 359.1M | 21.0M | 47.0M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 0 | 3.9M | 0 | 167.9K | 13.1M |
Short-term Debt | 47.6M | 42.2M | 0 | 0 | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 5.1M | 4.1M | 1.0K | 239.8K | 239.8K |
Total Current Liabilities | 52.9M | 50.3M | 15.2M | 937.2K | 27.6M |
Non-Current Liabilities | |||||
Long-term Debt | 214.5M | 471.9M | 322.7M | 0 | 0 |
Deferred Tax Liabilities | 5.0M | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1.0K | 1.0K | -1.0K | 26.6K | 27.3K |
Total Non-Current Liabilities | 219.5M | 471.9M | 322.7M | 26.6K | 27.3K |
Total Liabilities | 272.4M | 522.2M | 337.9M | 963.8K | 27.6M |
Equity | |||||
Common Stock | 186.4M | 20.7M | 20.7M | 20.7M | 20.7M |
Retained Earnings | - | -5.4M | -1.9M | -3.1M | -3.6M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 323.8M | 17.7M | 21.2M | 20.0M | 19.4M |
Key Metrics | |||||
Total Debt | 262.1M | 514.1M | 322.7M | 0 | 0 |
Working Capital | 95.1M | 62.4M | 40.1M | 10.0M | 4.5M |
Balance Sheet Composition
Arunjyoti Bio Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -3.4M | -13.0M | 1.6M | 760.2K | 922.5K |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | 0 | 0 | - |
Working Capital Changes | -31.8M | 33.4M | -131.8M | 4.4M | 5.0M |
Operating Cash Flow | -12.1M | 40.9M | -130.3M | 5.1M | 5.9M |
Investing Activities | |||||
Capital Expenditures | -58.7M | -233.3M | -191.9M | 0 | 0 |
Acquisitions | - | - | 0 | 0 | 0 |
Investment Purchases | - | - | 0 | 0 | 0 |
Investment Sales | - | - | 0 | 0 | 0 |
Investing Cash Flow | -58.7M | -233.3M | -191.9M | 0 | 0 |
Financing Activities | |||||
Share Repurchases | - | - | 0 | 0 | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | 143.3M | 322.7M | 0 | 0 |
Debt Repayment | - | - | - | - | 0 |
Financing Cash Flow | 329.7M | 184.8M | 322.7M | 0 | 0 |
Free Cash Flow | -44.2M | -170.2M | -322.5M | -7.8M | -3.1M |
Net Change in Cash | 258.9M | -7.5M | 588.0K | 5.1M | 5.9M |
Cash Flow Trend
Arunjyoti Bio Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
55.46
Price to Book
3.30
Price to Sales
4.16
Profitability Ratios
Profit Margin
-4.34%
Operating Margin
31.87%
Return on Equity
-5.63%
Return on Assets
-3.06%
Financial Health
Current Ratio
2.80
Debt to Equity
80.95
Beta
-0.49
Per Share Data
EPS (TTM)
₹-0.10
Book Value per Share
₹1.79
Revenue per Share
₹1.40
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
abvl | 1.1B | 55.46 | 3.30 | -5.63% | -4.34% | 80.95 |
BLS International | 163.3B | 28.90 | 9.44 | 25.17% | 23.43% | 17.79 |
CMS Info Systems | 73.1B | 19.77 | 3.22 | 16.43% | 15.30% | 8.36 |
PDS | 45.6B | 30.12 | 2.76 | 9.14% | 1.16% | 71.79 |
Intelligent Supply | 36.6B | 272.73 | - | -3.90% | 99.63% | 1.04 |
Hinduja Global | 25.0B | 60.39 | 0.32 | 1.55% | -0.61% | 24.74 |
Financial data is updated regularly. All figures are in the company's reporting currency.